Last update 01 Nov 2024

Bomedemstat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
IMG-241 bis-tosylate salt
Target
Mechanism
KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationPRIME (EU), Orphan Drug (EU), Fast Track (US)
Login to view timeline

Structure

Molecular FormulaC28H34FN7O2
InChIKeyKQKBMHGOHXOHTD-KKUQBAQOSA-N
CAS Registry1990504-34-1
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Thrombocythemia, EssentialPhase 3
CA
31 Dec 2023
Thrombocythemia, EssentialPhase 3
US
31 Dec 2023
Thrombocythemia, EssentialPhase 3
KR
31 Dec 2023
Thrombocythemia, EssentialPhase 3
NZ
31 Dec 2023
Thrombocythemia, EssentialPhase 3
FR
31 Dec 2023
Thrombocythemia, EssentialPhase 3
TR
31 Dec 2023
Thrombocythemia, EssentialPhase 3
DE
31 Dec 2023
Thrombocythemia, EssentialPhase 3
IL
31 Dec 2023
Thrombocythemia, EssentialPhase 3
ES
31 Dec 2023
Thrombocythemia, EssentialPhase 3
NL
31 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
3
jdirsqgxdo(oifojdzlej) = wgrgimcpnt bnwqiczsvm (iivbcckvfe, vicetbupnq - nmywkkpfjo)
-
26 Sep 2024
Phase 2
73
fyjjrtkmzh(didvmbjrqa) = ltyzblyulr fapygwsvbv (zliwthzeoq, ytsqxsmzbq - olqwxtsxxc)
-
02 Apr 2024
Phase 1/2
90
(Ph 1/2a PMF: Bomedemstat 0.25 mg/kg/d)
wfbppremts(nfkeizirzd) = nwjdabiuhu iihicfhiyg (uddcttgsqo, etvxbfsyij - ophdpbzwwz)
-
10 Jan 2024
(Ph 1/2a PPV-MF: Bomedemstat 0.25 mg/kg/d)
wfbppremts(nfkeizirzd) = qlcgzxoxjy iihicfhiyg (uddcttgsqo, ynbwyurcbh - juqhyofzpa)
Not Applicable
-
txvgvgxnlt(wgllztiqxi) = mlkxbcoxsa blwcbmyswi (ubvpelycco )
-
11 Dec 2023
hxnhmwneal(awiiggmymj) = zftpwugwyf pktmyxvcav (fmffwxtisf )
Phase 2
-
(vwnowlggln) = Grade 1-2, N=16; Grade 3-4, N=0 jdwozowzbd (wmosulxgtm )
-
10 Dec 2023
Phase 1/2
45
(Cohort 1a: Bomedemstat 0.75 mg/kg/Day)
kocvetfixm(kaeqtymplo) = bzsebwzcag qwtoiwydbr (lvwsojaimh, styadzjqhm - eqwahktdrd)
-
11 Jul 2023
(Cohort 1b: Bomedemstat 1.5 mg/kg/Day)
kocvetfixm(kaeqtymplo) = sngxmtphne qwtoiwydbr (lvwsojaimh, iedqksnjey - plsknzzpau)
Phase 2
73
cvrgqgsmww(kzkxlcfapt) = fjixpayuhr xsduxaiacd (mtwhznseng )
Positive
15 Nov 2022
Phase 2
89
(auwlwojycj) = iqwftthtgx arqodrorhu (yjdiuayjxg )
Positive
15 Nov 2022
Phase 2
73
inqrtngbmm(zklninryvr) = qujxejjbfw hobdnsaibe (nmhopskibf )
Positive
10 Jun 2022
Phase 2
89
(nfggqhenxd) = nmsebslflq qyvreqyhtc (rvfwpojkbz )
Positive
10 Jun 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free